Jia Jie Biomedical Co (ROCO:4109) Current Ratio: 3.36 (As of Dec. 2025) — 56% Above Median


ROCO:4109 Jia Jie Biomedical Co Ltd ROCO:4109
60 GF Score
Price NT$12.00
GF Value NT$16.93
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Jia Jie Biomedical Co Current Ratio?

Jia Jie Biomedical Co ROCO:4109 60 Current Ratio is 3.36 as of Dec. 2025, which is 56% above its 10-year median of 2.16. GuruFocus rates ROCO:4109 with a GF Score™ of 60/100 and a GF Value™ of NT$16.93 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,991 Consumer Packaged Goods companies, Jia Jie Biomedical Co ranks better than 78.6% on this metric.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Jia Jie Biomedical Co's current ratio for the quarter that ended in Dec. 2025 was 3.36.

Jia Jie Biomedical Co has a current ratio of 3.36. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for Jia Jie Biomedical Co's Current Ratio or its related term are showing as below:

ROCO:4109' s Current Ratio Range Over the Past 10 Years
Min: 0.66   Med: 2.16   Max: 4.79
Current: 3.36

During the past 13 years, Jia Jie Biomedical Co's highest Current Ratio was 4.79. The lowest was 0.66. And the median was 2.16.

ROCO:4109's Current Ratio is ranked better than
78.6% of 1991 companies
in the Consumer Packaged Goods industry
Industry Median: 1.73 vs ROCO:4109: 3.36

Jia Jie Biomedical Co  (ROCO:4109) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Jia Jie Biomedical Co Current Ratio Related Terms


Jia Jie Biomedical Co Current Ratio Historical Data

* Premium members only.

The historical data trend for Jia Jie Biomedical Co's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jia Jie Biomedical Co Current Ratio Chart

Jia Jie Biomedical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.15 4.31 1.30 2.98 3.36

Jia Jie Biomedical Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.98 3.67 3.91 3.93 3.36

ROCO:4109 vs KHC, GIS: Current Ratio Comparison

For the Packaged Foods subindustry, Jia Jie Biomedical Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jia Jie Biomedical Co Current Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Jia Jie Biomedical Co's Current Ratio distribution charts can be found below:

* The bar in red indicates where Jia Jie Biomedical Co's Current Ratio falls into.


ROCO:4109
60GF Score
Jia Jie Biomedical Co Ltd ROCO:4109
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jia Jie Biomedical Co Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Jia Jie Biomedical Co's Current Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Current Ratio (A: Dec. 2025 )=Total Current Assets (A: Dec. 2025 )/Total Current Liabilities (A: Dec. 2025 )
=574.476/170.835
=3.36

Jia Jie Biomedical Co's Current Ratio for the quarter that ended in Dec. 2025 is calculated as

Current Ratio (Q: Dec. 2025 )=Total Current Assets (Q: Dec. 2025 )/Total Current Liabilities (Q: Dec. 2025 )
=574.476/170.835
=3.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 3.36 mean?
Jia Jie Biomedical Co (ROCO:4109) has a Current Ratio of 3.36 as of Dec. 2025. This is 56% above median its historical median of 2.16. Over the past decade, Jia Jie Biomedical Co's Current Ratio has ranged from 0.66 to 4.79. According to the industry distribution chart, Jia Jie Biomedical Co ranks #426 out of 1991 companies in the Consumer Packaged Goods industry, placing it in the top 21.4%.
Is Jia Jie Biomedical Co's Current Ratio too high?
Jia Jie Biomedical Co's current Current Ratio of 3.36 is 56% above median its 10-year median of 2.16. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 4.79. The Consumer Packaged Goods industry median Current Ratio is 1.73. Jia Jie Biomedical Co's value of 3.36 is 94.2% above this industry median. Based on the distribution chart, Jia Jie Biomedical Co ranks #426 out of 1991 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Jia Jie Biomedical Co has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jia Jie Biomedical Co's Current Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Jia Jie Biomedical Co ranks #426 out of 1991 companies for Current Ratio. This places Jia Jie Biomedical Co in the top 21% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.73. Jia Jie Biomedical Co's value of 3.36 is 94.2% above this benchmark. Historically, Jia Jie Biomedical Co's own Current Ratio has ranged from 0.66 to 4.79 over the past decade. While the company's 10-year median is 2.16 vs. the industry median of 1.73, Jia Jie Biomedical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Consumer Packaged Goods company?
The median Current Ratio among Consumer Packaged Goods companies is 1.73, based on 1,991 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jia Jie Biomedical Co's current Current Ratio of 3.36 is 94.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median Current Ratio is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jia Jie Biomedical Co's current Current Ratio is 3.36, which is 56% above median its own 10-year median of 2.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jia Jie Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Jia Jie Biomedical Co (ROCO:4109) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$16.93, compared to a current price of NT$12.00 — trading 29.1% below its estimated fair value. The current Current Ratio is 3.36, which is 56% above median its 10-year median of 2.16 and 94.2% above the Consumer Packaged Goods industry median of 1.73. Jia Jie Biomedical Co's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Jia Jie Biomedical Co (ROCO:4109), the current Current Ratio is 3.36 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jia Jie Biomedical Co (ROCO:4109) Overvalued in 2026?

Based on GuruFocus' analysis, Jia Jie Biomedical Co stock appears to be undervalued. The current stock price of NT$12.00 is trading 29.1% below its estimated GF Value™ of NT$16.93. GuruFocus considers Jia Jie Biomedical Co to be Modestly Undervalued.

Key valuation signals for ROCO:4109:

  • Current Ratio: 3.36 (56% above median its 10-year median of 2.16)
  • GF Value™: NT$16.93 vs. price of NT$12.00 (29.1% below fair value)
  • GF Score™: 60/100 with 4 warning signs
  • Industry Position: 94.2% above the Consumer Packaged Goods median (#426 of 1991)

No single metric tells the full story. See the ROCO:4109 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jia Jie Biomedical Co Business Description

Address Jiuru 1st Road, 3rd Floor, No. 61, Sanmin District, Kaohsiung City, TWN, 807
Jia Jie Biomedical Co Ltd is a Taiwan-based company. The Company is engaged in the processing, sale, and trading of softshell turtle food, the Manufacture of Dairy Products, and miscellaneous food manufacturing (e.g., softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules). The company is also engaged in the import, export of the aforementioned products, the distribution, bidding, and quotation of aforementioned products for domestic and foreign manufacturers, Wholesale of Nonalcoholic Beverages, candy wholesale, baked food wholesale, supplementary food wholesale, cosmetics wholesale, and sports equipment wholesale.
60GF Score

Get the complete analysis for ROCO:4109

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$12.00
Price
NT$16.93
GF Value